Ventilator Assisted Pneumonia (VAP)

Ventilator Assisted Pneumonia (VAP) is a relevant topic which cannot be overlooked due to its significant effect on health care cost, prolonged hospital stay and eventual cause of death if untreated. It’s considered a hospital-acquired infection triggered by the aspiration of bacteria past the endotracheal cuff after 48 hours of being intubated, which can develop into pneumonia (Roberts and Moule, 2011). Your poster was precisely displayed with concise points on the key elements. I was amazed by the addition of $40,000 to each admission cost and the increament of risk of death due to VAP. This supports the importance of reducing this problem in intensive care units where it normally happens. I enjoyed reading your post and support your effort
to reduce this problem through research.